FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2474824740> ?p ?o ?g. }

• W2474824740 endingPage "168" @default.
• W2474824740 startingPage "166" @default.
• W2474824740 abstract "Special CommunicationSickle Cell Disease in Saudi Arabia: The Asian HaplotypeReflections on a Meeting at Hofuf, September 2003 Graham R. Serjeant and MD, FRCP Beryl E. SerjeantFIMLS Graham R. Serjeant Search for more papers by this author and Beryl E. Serjeant Search for more papers by this author Published Online:3 Jun 2004https://doi.org/10.5144/0256-4947.2004.166SectionsPDF ToolsAdd to favoritesDownload citationTrack citations ShareShare onFacebookTwitterLinked InRedditEmail AboutIntroductionRecent developments in sickle cell disease were reviewed at a research meeting in Hofuf held in September 2003, having been postponed from May 2003 because of events within the region. The meeting brought together speakers and researchers from all over the Kingdom along with visiting speakers from India, Nigeria, Greece, Bahrain, Sudan and Jamaica. Although the emphasis of the meeting was on recent advances, it was a timely reminder of the research opportunities posed by the Asian haplotype of the disease prevalent in the Eastern Province. The Asian haplotype refers to a variant of the DNA structure flanking the β–globin locus (the site of the HbS gene), which is not encountered in African populations and appears to represent an independent occurrence of the HbS mutation. This haplotype is confined to peoples of the Eastern Province of Saudi Arabia and to India, and contrasts with African populations, where the HbS gene is associated with different DNA structures, named Benin, Senegal, and Bantu (or Central African Republic) after the places where they were first described. The interesting feature of the Asian haplotype is the extent to which it modifies the haematological and clinical expression of homozygous sickle cell (SS) disease.The DNA structure of the Asian haplotype was first recognized in Jamaica in an Indian family with SS disease1 who also had high levels of fetal haemoglobin (HbF). Early reports from the Eastern Province, especially from the ARAMCO facility in Dhahran reported unusually mild features in SS disease2–6 and near normal survival.7 The disease was characterized by high levels of HbF and most cases coincided with α-thalassaemia, both features believed to inhibit intravascular sickling. As a result, splenic architecture and splenic function persisted,8 minimizing the risk of pneumococcal septicaemia characteristic of African SS disease.9 Other features of clinical mildness included less frequent acute chest syndrome, leg ulceration and priapism,10 and less cumulative damage to neurological, pulmonary and renal function, which commonly contributes to death in African disease. The overall impression was of a disease process milder than that of African patients.However, serious pathology in association with the Asian haplotype has been described. Lack of splenic pathology might be expected to protect against acute splenic sequestration and chronic hypersplenism, but it is clear that these occur.11 There are insufficient data to determine whether the incidence is similar or less than in African disease. Priapism also occurs and can cause impotence, but its prevalence is unknown. It is also clear that bone pathology continues to cause major symptomatology through painful crises, avascular necrosis of femoral and humeral heads, and osteomyelitis. Data on retardation of physical and sexual development are not yet available and would contribute to the overall picture of disease associated with the Asian haplotype. The Hofuf meeting added further to the catalogue of problems encountered in the ‘relatively benign’ disease of the Eastern Province, addressing acute chest syndrome, acute splenic sequestration, hypersplenism, priapism, problems in pregnancy, and avascular necrosis of the femoral head, as well as aspects of management such as pregnancy and cholecystectomySo where do all these observations lead? Is the Asian haplotype really associated with more mild disease? The truth is that the present data are difficult to evaluate in the absence of true incidence or unbiased prevalence figures. Chronic end-organ damage does appear to be less frequent, serious problems in early childhood less common, and survival is probably increased, but considerable morbidity may occur from recurrent, acute painful crises and from the chronic bone damage of avascular necrosis and osteomyelitis. This may seem a daunting prospect for a disease where median survival may exceed 50 years, but two studies are already underway. From 1982, researchers at King Faisal University, Dammam screened 14 122 births and detected 129 babies with SS disease, most of whom were followed for 5 to 8 years.8,12,13 Although funding for this study ceased in 1990, it is to be hoped that many participants could still be located, interviewed and followed intermittently with documentation of their clinical course and survival. Another study based at King Faisal University, Dammam, screened births for one year at King Fahad Hospital, Hofuf, several years ago (Dr. Mohammed K. Al-Abdul Aali, personal communication). Although the study contributed to prevalence figures, no attempt was made to follow-up these children. If records persist, contact with these subjects now and in the future could provide important data. With so many Saudi doctors interested in sickle cell disease, follow-up of these two populations should have the highest priority.Sickle cell disease in the Eastern Province provides exciting opportunities for genetic research aimed at understanding the relationship between the Asian haplotype, high levels of HbF and frequent α-thalassaemia. Alpha-thalassaemia is predominantly of the deletional type, and since the responsible gene is on chromosome 16, whereas the HbS mutation resides on chromosome 11, direct linkage seems unlikely. More probable is the simultaneous selection of both genes, HbS and α-thalassaemia, possibly because in the past, both have conferred a survival advantage against malaria in early childhood. In this context, it is interesting that α-thalassaemia is commonly associated with SS disease in almost all populations with the exception of Greek patients.14 The Eastern Saudi population also provides an opportunity for clarifying the complex interaction of α-thalassaemia and SS disease, which has reached conflicting conclusions elsewhere.15,16Similar opportunities exist for exploring the genetics and clinical effects of high levels of HbF. The general perception that high levels of HbF ameliorate African SS disease is currently supported by limited data,17–20 and analysis of its effect on survival is confounded by the continuing age-related fall in HbF in older patients. The genetics is even more confusing since definition of the genes for heterocellular hereditary persistence of HbF is not yet possible. At a cellular level, HbF synthesis is elevated in erythroid progenitor cultures from Saudi Arabian patients from the Eastern Province,21 which is consistent with a genetic mechanism, but a commonly occurring polymorphism at -158 to the cap site of the Gγ gene was not closely linked to HbF levels.22 These authors did not find elevated HbF levels in sickle cell trait (AS) parents of SS patients with high HbF levels and suggested that the haemolytic stress of SS disease was necessary for the expression of high HbF levels. However, HbF levels were influenced by the HbF level of AS parents in African23 and Indian24 patients with SS disease, and in India the HbF level in AS parents of SS subjects was directly related to the number of copies of the Asian haplotype.24,25 The fact that SS patients homozygous for the Asian haplotype manifest wide variation in HbF levels 10,26 indicates the importance of factors other than the Asian haplotype itself.Clinically, it is clear that bone pain crises remain a major cause of morbidity and hospital admission. In this context, it is interesting to note that a high haemoglobin level is an important risk factor for bone pain in African SS disease.19,27 Patients in the Eastern Province manifest high haemoglobin levels and it is important to determine whether this is also a risk factor for bone pain in that area. If confirmed, this would be an opportunity for a trial of venesection in reducing haemoglobin and preventing bone pain, long conjectured in African SS disease but currently based only on anecdotal data.The conference recently held at Hofuf brought together many Saudi professionals, and illustrated the degree of interest in SS disease and the increasing recognition that SS disease in the Eastern Province is not uniformly benign. The Chairman of the Conference, Dr. Khalifa Nasser K. Al Mulhim, and his organizing committee are to be congratulated on a conference that not only highlighted the problems of the disease, but also emphasized the research opportunities. It is to be hoped that this will act as a stimulus to a concerted, collaborative research programme that will address many of the problems and opportunities detailed above.ARTICLE REFERENCES:1. Wainscoat JS, Thein SL, Higgs DR, Bell JI, Weatherall DJ, Al-Awamy BH, Serjeant GR. A genetic marker for elevated levels of haemoglobin F in homozygous sickle cell disease? Br J Haematol. 1985; 60:261-268. Google Scholar2. Perrine RP. Cholelithiasis in sickle cell anemia in a Caucasian population . Am J Med. 1973; 54:327-332. Google Scholar3. Perrine RP, John P. Pregnancy in sickle cell anemia in a Caucasian group . Am J Obstet Gynecol. 1974; 118:29-33. Google Scholar4. Perrine RP, Brown MJ, Clegg JB, Weatherall DJ, May A. Benign sickle cell anaemia . Lancet. 1972; ii:1163-1167. Google Scholar5. Perrine RP, Pembrey ME, John P, Perrine S, Shoup F. Natural history of sickle cell anemia in Saudi Arabs. A study of 270 subjects . Ann Intern Med. 1978; 88:1-6. Google Scholar6. Perrine RP, John P, Pembrey M, Perrine S. Sickle cell disease in Saudi Arabs in early childhood . Arch Dis Child. 1981; 56:187-192. Google Scholar7. Gelpi AP. Benign sickle cell disease in Saudi Arabia: survival estimate and population dynamics . Clin Genet. 1979; 15:307-310. Google Scholar8. Al-Awamy B, Wilson WA, Pearson HA. Splenic function in sickle cell disease in the Eastern Province of Saudi Arabia . J Pediatr. 1984; 104:714-717. Google Scholar9. El Mouzan MI, Al Awamy BH, Absood G. Infections and sickle cell disease in eastern Saudi Arabian children . Am J Dis Child. 1989; 143:205-227. Google Scholar10. Padmos MA, Roberts GT, Sackey K, Kulozik A, Bail S, Morris JS, Serjeant BE, Serjeant GR. Two different forms of homozygous sickle cell disease occur in Saudi Arabia . Br J Haematol. 1991; 79:93-98. Google Scholar11. Al-Salem AH, Qaisaruddin S, Nasserullah Z, Al Dabbous I, Abu Srair H, Al Jam’a A. Splenectomy and acute splenic sequestration crises in sickle cell disease . Pediatr Surg Int. 1995; 11:26-28. Google Scholar12. Al-Awamy BH, Al-Muzan M, Al-Turki M, Serjeant GR. Neonatal screening for sickle cell disease in the Eastern Province of Saudi Arabia . Trans Roy Soc Trop Med Hyg. 1984; 78:792-794. Google Scholar13. Al-Awamy BH, Niazi GA, Al-Muzan MI, Al-Turki MT, Naeem MA. Relationship of haemoglobin F and alpha thalassaemia to severity of sickle-cell anaemia in the Eastern Province of Saudi Arabia . Ann Trop Paediatr. 1986; 6:261-265. Google Scholar14. Christakis J, Vavatsi N, Hassapopoulou H, Papadopoulou M, Mandraveli K, Loukopoulos D, Morris J, Serjeant BE, Serjeant GR. Comparison of homozygous sickle cell disease in Northern Greece and Jamaica . Lancet. 1990; 335:637-640. Google Scholar15. Embury SH, Dozy AM, Miller J, Davis JR, Kleman KM, Preisler H, Vichinsky E, Lande WN, Lubin BH, Kan YW, Mentzer WC. Concurrent sickle-cell anemia and alpha-thalassemia. Effect on severity of anemia . N Engl J Med. 1982; 306:270-274. Google Scholar16. Higgs DR, Aldridge BE, Lamb J, Clegg JB, Weatherall DJ, Hayes RJ, Grandison Y, Lowrie Y, Mason KP, Serjeant BE, Serjeant GR. The interaction of alpha-thalassemia and homozygous sickle-cell disease . N Engl J Med. 1982; 306:1441-1446. Google Scholar17. Serjeant GR. Fetal haemoglobin in homozygous sickle cell disease . Clin Haematol. 1975; 4:109-122. Google Scholar18. Stevens MCG, Hayes RJ, Vaidya S, Serjeant GR. Fetal hemoglobin and clinical severity of homozygous sickle cell disease in early childhood . J Pediatr. 1981; 98:37-41. Google Scholar19. Platt OS, Thorington BD, Brambilla DJ, Milner PF, Rosse WF, Vichinsky E, Kinney TR. Pain in sickle cell disease. Rates and risk factors . N Engl J Med. 1991; 325:11-16. Google Scholar20. Bailey K, Morris JS, Serjeant GR. Fetal haemoglobin and early manifestations of homozygous sickle cell disease . Arch Dis Child. 1992; 67:517-520. Google Scholar21. Miller BA, Salameh M, Ahmed M, Wainscoat J, Antognetti G, Orkin S, Weatherall D, Nathan DG. High fetal hemoglobin production in sickle cell anemia in the Eastern Province of Saudi Arabia is genetically determined . Blood. 1986; 67:1404-1410. Google Scholar22. Miller BA, Olivieri N, Salameh M, Ahmed M, Antognetti G, Huisman THJ, Nathan DG, Orkin SH. Molecular analysis of the high-hemoglobin-F phenotype in Saudi Arabian sickle cell anemia . N Engl J Med. 1987; 316:244-250. Google Scholar23. Mason KP, Grandison Y, Hayes RJ, Serjeant BE, Serjeant GR, Vaidya S, Wood WG. Post-natal decline offetal haemoglobin in homozygous sickle cell disease: relationship to parental HbF levels . Br J Haematol. 1982; 52:455-463. Google Scholar24. Kulozik AE, Thein SL, Kar BC, Wainscoat JS, Serjeant GR, Weatherall DJ. Raised HbF levels in sickle cell disease are caused by a determinant linked to the beta-globin gene cluster . In: Stamatoyannopoulos G, Liss AR. Hemoglobin Switching V. New York, 1987;427-439. Google Scholar25. Kulozik AE, Kar BC, Satapathy RK, Serjeant BE, Serjeant GR, Weatherall DJ. Fetal hemoglobin levels and bs globin haplotypes in an Indian population with sickle cell disease . Blood. 1987; 69:1742-1746. Google Scholar26. Kar BC, Satapathy RK, Kulozik AE, Kulozik M, Sirr S, Serjeant BE, Serjeant GR. Sickle cell disease in Orissa State, India . Lancet. 1986; ii:1198-201. Google Scholar27. Baum KF, Dunn DT, Maude GH, Serjeant GR. The painful crisis of homozygous sickle cell disease: a study of risk factors . Arch Int Med. 1987; 147:1231-1234. Google Scholar Previous article Next article FiguresReferencesRelatedDetails Volume 24, Issue 3May-June 2004 Metrics History Accepted1 February 2004Published online3 June 2004 InformationCopyright © 2004, Annals of Saudi MedicineThis work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.PDF download" @default.
• W2474824740 created "2016-07-22" @default.
• W2474824740 creator A5060324072 @default.
• W2474824740 creator A5091187132 @default.
• W2474824740 date "2004-05-01" @default.
• W2474824740 modified "2023-09-27" @default.
• W2474824740 title "Sickle Cell Disease in Saudi Arabia: The Asian Haplotype" @default.
• W2474824740 cites W1493998812 @default.
• W2474824740 cites W1969275289 @default.
• W2474824740 cites W1993807606 @default.
• W2474824740 cites W2003399956 @default.
• W2474824740 cites W2003566721 @default.
• W2474824740 cites W2004145496 @default.
• W2474824740 cites W2004203135 @default.
• W2474824740 cites W2018585773 @default.
• W2474824740 cites W2023346445 @default.
• W2474824740 cites W2024571301 @default.
• W2474824740 cites W2028339850 @default.
• W2474824740 cites W2029427557 @default.
• W2474824740 cites W2029907762 @default.
• W2474824740 cites W2036150788 @default.
• W2474824740 cites W2066521171 @default.
• W2474824740 cites W2069133951 @default.
• W2474824740 cites W2093209682 @default.
• W2474824740 cites W2115274846 @default.
• W2474824740 cites W2116953481 @default.
• W2474824740 cites W2135276771 @default.
• W2474824740 cites W2168300377 @default.
• W2474824740 cites W2207249111 @default.
• W2474824740 cites W2239199111 @default.
• W2474824740 cites W2322074970 @default.
• W2474824740 cites W2412158715 @default.
• W2474824740 cites W2415883493 @default.
• W2474824740 cites W2440526517 @default.
• W2474824740 cites W4252520590 @default.
• W2474824740 cites W4302604433 @default.
• W2474824740 doi "https://doi.org/10.5144/0256-4947.2004.166" @default.
• W2474824740 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6147937" @default.
• W2474824740 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/15307451" @default.
• W2474824740 hasPublicationYear "2004" @default.
• W2474824740 type Work @default.
• W2474824740 sameAs 2474824740 @default.
• W2474824740 citedByCount "6" @default.
• W2474824740 countsByYear W24748247402012 @default.
• W2474824740 countsByYear W24748247402019 @default.
• W2474824740 crossrefType "journal-article" @default.
• W2474824740 hasAuthorship W2474824740A5060324072 @default.
• W2474824740 hasAuthorship W2474824740A5091187132 @default.
• W2474824740 hasBestOaLocation W24748247401 @default.
• W2474824740 hasConcept C104317684 @default.
• W2474824740 hasConcept C126322002 @default.
• W2474824740 hasConcept C135763542 @default.
• W2474824740 hasConcept C197754878 @default.
• W2474824740 hasConcept C2779134260 @default.
• W2474824740 hasConcept C54355233 @default.
• W2474824740 hasConcept C71924100 @default.
• W2474824740 hasConcept C86803240 @default.
• W2474824740 hasConceptScore W2474824740C104317684 @default.
• W2474824740 hasConceptScore W2474824740C126322002 @default.
• W2474824740 hasConceptScore W2474824740C135763542 @default.
• W2474824740 hasConceptScore W2474824740C197754878 @default.
• W2474824740 hasConceptScore W2474824740C2779134260 @default.
• W2474824740 hasConceptScore W2474824740C54355233 @default.
• W2474824740 hasConceptScore W2474824740C71924100 @default.
• W2474824740 hasConceptScore W2474824740C86803240 @default.
• W2474824740 hasIssue "3" @default.
• W2474824740 hasLocation W24748247401 @default.
• W2474824740 hasLocation W24748247402 @default.
• W2474824740 hasLocation W24748247403 @default.
• W2474824740 hasLocation W24748247404 @default.
• W2474824740 hasOpenAccess W2474824740 @default.
• W2474824740 hasPrimaryLocation W24748247401 @default.
• W2474824740 hasRelatedWork W1587668020 @default.
• W2474824740 hasRelatedWork W1965396974 @default.
• W2474824740 hasRelatedWork W1981169569 @default.
• W2474824740 hasRelatedWork W1983642025 @default.
• W2474824740 hasRelatedWork W1998686087 @default.
• W2474824740 hasRelatedWork W2038331681 @default.
• W2474824740 hasRelatedWork W2044943383 @default.
• W2474824740 hasRelatedWork W2050778956 @default.
• W2474824740 hasRelatedWork W2260169894 @default.
• W2474824740 hasRelatedWork W2330151095 @default.
• W2474824740 hasVolume "24" @default.
• W2474824740 isParatext "false" @default.
• W2474824740 isRetracted "false" @default.
• W2474824740 magId "2474824740" @default.
• W2474824740 workType "article" @default.